Nitric oxide (NO) is an important regulator of gut function but its role in gut injury and inflammation is uncertain. Under acute conditions NO protects the gut from a variety of vascular and luminal insults. However under more chronic conditions inhibition of NO formation prevents gut injury. The reasons for this disparity appears to lie in the enzyme source for NO production. Nitric oxide-mediated gut injury is the result of inducible nitric oxide synthase (iNOS), whereas the protective effects of NO reflect the constitutive form (cNOS). Unlike cNOS, iNOS is transcriptionally regulated and releases large amounts of NO (1000x more than cNOS) for the life of the enzyme. Thus, iNOS is a marker and a mediator of gut injury. Necrotizing enterocolitis (NEC) is a devastating neonatal disease of unknown etiology. Gut necrosis with NEC probably represents the end result of diverse events. Infectious agents, limited mucosal maturation and gut motility as a result of the prematurity, and aggressive feeding patterns are thought to contribute, probably in combination. The working hypothesis of this proposal is the iNOS is induced in NEC and the iNOS gene expression will be detectable in both intestinal tissue and circulating leukocytes by reverse transcriptase polymerase chain reaction (RT-PCR). Furthermore, NOS inhibitors selective for the inducible form may protect neonatal gut from damage. These hypotheses will be tested in several adult and neonatal models of NEC, with studies on NOS gene expression supported by biochemical tests quantifying NO production. Rat and guinea pig models of NEC gut inflammation include trinitrobenzene sulfonic acid, luminal acetic and + casein, and luminal fast fermenting bacteria (anerobes or aerobes) with infant formula. We have published extensively with all models. Gut injury will be assessed by a variety of in vivo functional tests, morphology (including immunohistochemistry) and mediator release. The advantages of this approach to the diagnosis of NEC is that iNOS is normally quiescent with gene expression induced by bacterial products (endotoxin) and/or cytokine responses. Furthermore we have demonstrated that iNOS mRNA is detectable in circulating leukocytes following in vivo exposure to LPS, suggesting that a direct application to premature infants is readily accomplished. A lack of cNOS may also contribute to the pathophysiology of NEC, possible due to developmental deficiencies. While a cNOS deficiency will also be testable in our animal models, this hypothesis is not easily evaluated in premature infants due to problems in obtaining endothelial cells or gut biopsies. This proposal focuses on a novel and sensitive approach to the diagnosis of NEC, one which provides insight into the pathophysiology and the possibility of new therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD031885-04
Application #
2392457
Study Section
Special Emphasis Panel (SRC (05))
Project Start
1994-04-01
Project End
1999-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Louisiana State University Hsc New Orleans
Department
Pediatrics
Type
Schools of Medicine
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
Piscoya, J; Rodriguez, Z; Bustamante, S A et al. (2001) Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflamm Res 50:442-8
Liu, X; Miller, M J; Joshi, M S et al. (1998) Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A 95:2175-9
Sandoval-Chacon, M; Thompson, J H; Zhang, X J et al. (1998) Antiinflammatory actions of cat's claw: the role of NF-kappaB. Aliment Pharmacol Ther 12:1279-89
Liu, X; Miller, M J; Joshi, M S et al. (1998) Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 273:18709-13
Zhang, X J; Thompson, J H; Mannick, E E et al. (1998) Localization of inducible nitric oxide synthase mRNA in inflamed gastrointestinal mucosa by in situ reverse transcriptase-polymerase chain reaction. Nitric Oxide 2:187-92
Sandoval, M; Zhang, X J; Liu, X et al. (1997) Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: attenuation by L-ascorbic acid. Free Radic Biol Med 22:489-95
Sandoval, M; Liu, X; Mannick, E E et al. (1997) Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 113:1480-8
Ribbons, K A; Thompson, J H; Liu, X et al. (1997) Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur J Pharmacol 323:245-54
Bustamante, S A; Pang, Y; Romero, S et al. (1996) Inducible nitric oxide synthase and the regulation of central vessel caliber in the fetal rat. Circulation 94:1948-53
Voelker, C A; Miller, M J; Zhang, X J et al. (1995) Perinatal nitric oxide synthase inhibition retards neonatal growth by inducing hypertrophic pyloric stenosis in rats. Pediatr Res 38:768-74

Showing the most recent 10 out of 12 publications